Evidence map›Paper›PMID 32592423›Full record

ArticleTransfusion2020

The use of cryopreserved platelets in a trauma-induced hemorrhage model.

Derek J B Kleinveld, Pieter H Sloos, Femke Noorman, M Adrie W Maas, Jesper Kers, Tim W H Rijnhout, Margreet Zoodsma, Rigo Hoencamp, Markus W Hollmann, Nicole P Juffermans

Open access · hybridAbstract read
In one paragraph

Article in Transfusion, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Proteomics: A Tool to Study Platelet Function.International journal of molecular sciences · 2021
    Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 3 countries.

Derek J B KleinveldDepartment of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.ORCID 0000-0002-6357-1471
Pieter H SloosDepartment of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Femke NoormanMilitary Blood Bank, Utrecht, The Netherlands.
M Adrie W MaasDepartment of Intensive Care, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Jesper KersDepartment of Pathology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Tim W H RijnhoutDepartment of Surgery, Alrijne Medical Center, Leiderdorp, The Netherlands.ORCID 0000-0002-2736-5101
Margreet ZoodsmaMilitary Blood Bank, Utrecht, The Netherlands.
Rigo HoencampDepartment of Surgery, Alrijne Medical Center, Leiderdorp, The Netherlands.
Markus W HollmannLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Nicole P JuffermansLaboratory of Experimental Intensive Care and Anesthesiology, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
Amsterdam Neuroscience · NLCentral Military Hospital · NLLeiden University · NLErasmus MC · NLOLVG · NL

Funding

Dutch Ministry of DefenseStichting Ziektekostenverzekering Krijgsmacht (SZVK)
6 · The paper itself

Abstract

backgroundCryopreserved platelet products can be stored for years and are mainly used in military settings. Following thawing, cryopreserved platelets are activated, resulting in faster clot formation but reduced aggregation in vitro, rendering their efficacy in bleeding unknown. Also, concerns remain on the safety of these products. The aim was to investigate the efficacy and safety of cryopreserved platelets in a rat model of traumatic hemorrhage. STUDY DESIGN AND

methodsAfter 1 hour of shock, rats (n = 13/group) were randomized to receive a balanced transfusion pack (1:1:1 red blood cell:plasma:platelet) made from syngeneic rat blood, containing either liquid stored platelets or cryopreserved platelets. Primary outcome was the transfusion volume required to obtain a mean arterial pressure (MAP) of 60 mmHg. Secondary outcomes were coagulation as assessed by thromboelastometry (ROTEM®) and organ failure as assessed by biochemistry and histopathology.

resultsThe transfusion volume to obtain a MAP of 60 mmHg was lower in animals receiving cryopreserved platelets (5.4 [4.1-7.1] mL/kg) compared to those receiving liquid stored platelets (7.5 [6.4-8.5] mL/kg, p < 0.05). ROTEM® clotting times were shorter (45 [41-48] vs. 49 [45-53]sec, p < 0.05), while maximum clot firmness was slightly lower (68 [67-68] vs. 69 [69-71]mm, p < 0.01). Organ failure was similar in both groups.

conclusionsUse of cryopreserved platelets required less transfusion volume to reach a targeted MAP compared to liquid stored platelets, while organ injury was similar. These results provide a rationale for clinical trials with cryopreserved platelets in (traumatic) bleeding.

Indexed as

Blood PlateletsBlood PreservationCryopreservationHemorrhagePlatelet TransfusionWounds and InjuriesAnimalsDisease Models, AnimalMaleRats

Identifiers

PMID32592423
PMCPMC7540664
OpenAlexW3037918339

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.